• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发一种使用 CRISPR/Cas9 系统生成敲除癌细胞系的优化方案,重点是瞬时转染。

Development of an optimized protocol for generating knockout cancer cell lines using the CRISPR/Cas9 system, with emphasis on transient transfection.

机构信息

Faculty of Advanced Science and Technology, Department of Genetics, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Microbiology Research Center, Tehran, Iran.

出版信息

PLoS One. 2024 Nov 14;19(11):e0310368. doi: 10.1371/journal.pone.0310368. eCollection 2024.

DOI:10.1371/journal.pone.0310368
PMID:39541329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11563393/
Abstract

The clustered regularly interspaced short palindromic repeats (CRISPR) system offers cost-effectiveness, high efficiency, precision, and ease of use compared to traditional gene editing techniques. In this study, we employed findings from prestigious investigations to develop an optimized approach for generating knockout cancer cell lines using a transient transfection method. This protocol introduces a distinctive approach that follows rigorous guidelines for designing gRNA to reduce off-target effects, a major challenge in CRISPR applications. Our step-by-step instructions allow researchers, particularly those with limited laboratory equipment and funding, as well as those undertaking CRISPR projects for the first time, to generate knockout cell lines using CRISPR technology in just ten weeks. This protocol covers all needs for enhancing various yields, such as transfection efficiency, and includes leveraging robust bioinformatics tools, conducting essential assays, isolating monoclonal cells via limiting dilution, validating knockout cells, and providing comprehensive troubleshooting recommendations. Using this method, we successfully created several new generations of colorectal cancer cell lines with monoallelic and biallelic knockouts of the epithelial cell adhesion molecule (EpCAM) gene. Our method, optimized for a wide spectrum of cancer cell lines, makes CRISPR more accessible for applications in personalized and precision medicine. It expands opportunities for novel investigations into cancer mechanisms and paves the way for potential therapeutic interventions.

摘要

与传统的基因编辑技术相比,簇状规律间隔短回文重复序列(CRISPR)系统具有成本效益高、效率高、精确性高和易于使用的特点。在这项研究中,我们利用权威研究的结果,开发了一种使用瞬时转染方法生成敲除癌细胞系的优化方法。该方案采用了一种独特的方法,严格遵循设计 gRNA 的指导方针,以减少 CRISPR 应用中的脱靶效应这一主要挑战。我们的分步说明允许研究人员,特别是那些实验室设备和资金有限的研究人员,以及那些首次进行 CRISPR 项目的研究人员,仅用十周时间即可使用 CRISPR 技术生成敲除细胞系。该方案涵盖了提高各种产量(如转染效率)的所有需求,并利用强大的生物信息学工具,进行必要的测定,通过有限稀释分离单克隆细胞,验证敲除细胞,并提供全面的故障排除建议。使用这种方法,我们成功地创建了几株新的结直肠癌细胞系,这些细胞系中上皮细胞黏附分子(EpCAM)基因的单等位基因和双等位基因敲除。我们的方法针对广泛的癌细胞系进行了优化,使 CRISPR 更易于在个性化和精准医疗中应用。它为癌症机制的新研究提供了机会,并为潜在的治疗干预铺平了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57f/11563393/fbc00944191c/pone.0310368.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57f/11563393/2a8322a7988d/pone.0310368.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57f/11563393/18a919c57fbf/pone.0310368.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57f/11563393/72081637d171/pone.0310368.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57f/11563393/58a203792021/pone.0310368.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57f/11563393/9f62c820ec6f/pone.0310368.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57f/11563393/af4deb86939f/pone.0310368.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57f/11563393/fbc00944191c/pone.0310368.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57f/11563393/2a8322a7988d/pone.0310368.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57f/11563393/18a919c57fbf/pone.0310368.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57f/11563393/72081637d171/pone.0310368.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57f/11563393/58a203792021/pone.0310368.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57f/11563393/9f62c820ec6f/pone.0310368.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57f/11563393/af4deb86939f/pone.0310368.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57f/11563393/fbc00944191c/pone.0310368.g007.jpg

相似文献

1
Development of an optimized protocol for generating knockout cancer cell lines using the CRISPR/Cas9 system, with emphasis on transient transfection.开发一种使用 CRISPR/Cas9 系统生成敲除癌细胞系的优化方案,重点是瞬时转染。
PLoS One. 2024 Nov 14;19(11):e0310368. doi: 10.1371/journal.pone.0310368. eCollection 2024.
2
A Robust Protocol for CRISPR-Cas9 Gene Editing in Human Suspension Cell Lines.一种用于人悬浮细胞系 CRISPR-Cas9 基因编辑的稳健方案。
Curr Protoc. 2021 Nov;1(11):e286. doi: 10.1002/cpz1.286.
3
CRISPR/Cas9-mediated 2-sgRNA cleavage facilitates pseudorabies virus editing.CRISPR/Cas9 介导的 2-sgRNA 切割促进伪狂犬病病毒编辑。
FASEB J. 2018 Aug;32(8):4293-4301. doi: 10.1096/fj.201701129R. Epub 2018 Mar 6.
4
Guide for generating single-cell-derived knockout clones in mammalian cell lines using the CRISPR/Cas9 system.使用 CRISPR/Cas9 系统在哺乳动物细胞系中生成单细胞来源的基因敲除克隆的指南。
Mol Cells. 2024 Jul;47(7):100087. doi: 10.1016/j.mocell.2024.100087. Epub 2024 Jun 25.
5
Protocol for establishing knockout cell clones by deletion of a large gene fragment using CRISPR-Cas9 with multiple guide RNAs.利用 CRISPR-Cas9 多重向导 RNA 缺失大片段基因建立基因敲除细胞克隆的方案。
STAR Protoc. 2024 Sep 20;5(3):103179. doi: 10.1016/j.xpro.2024.103179. Epub 2024 Jul 6.
6
An improved strategy for CRISPR/Cas9 gene knockout and subsequent wildtype and mutant gene rescue.一种改进的 CRISPR/Cas9 基因敲除策略,以及随后的野生型和突变型基因拯救。
PLoS One. 2020 Feb 13;15(2):e0228910. doi: 10.1371/journal.pone.0228910. eCollection 2020.
7
Gene Editing in B-Lymphoma Cell Lines Using CRISPR/Cas9 Technology.利用 CRISPR/Cas9 技术编辑 B 淋巴瘤细胞系中的基因。
Methods Mol Biol. 2020;2115:445-454. doi: 10.1007/978-1-0716-0290-4_25.
8
Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.依赖于强力霉素的 CRISPR-Cas9 自我失活以时间调节靶标和非靶标编辑。
Mol Ther. 2020 Jan 8;28(1):29-41. doi: 10.1016/j.ymthe.2019.09.006. Epub 2019 Sep 12.
9
Generation of a Knockout Mouse Embryonic Stem Cell Line Using a Paired CRISPR/Cas9 Genome Engineering Tool.使用配对的CRISPR/Cas9基因组工程工具生成敲除小鼠胚胎干细胞系
Methods Mol Biol. 2016;1341:321-43. doi: 10.1007/7651_2015_213.
10
Establishment of TP53-knockout canine cells using optimized CRIPSR/Cas9 vector system for canine cancer research.利用优化的 CRISPR/Cas9 载体系统建立 TP53 敲除犬细胞系,用于犬科癌症研究。
BMC Biotechnol. 2019 Jan 3;19(1):1. doi: 10.1186/s12896-018-0491-5.

引用本文的文献

1
Tissue nanotransfection and cellular reprogramming in regenerative medicine and antimicrobial dynamics.再生医学中的组织纳米转染与细胞重编程以及抗菌动力学
Front Bioeng Biotechnol. 2025 Jun 18;13:1558735. doi: 10.3389/fbioe.2025.1558735. eCollection 2025.
2
Current updates on the structural and functional aspects of the CRISPR/Cas13 system for RNA targeting and editing: A next‑generation tool for cancer management (Review).用于RNA靶向和编辑的CRISPR/Cas13系统的结构和功能方面的最新进展:癌症管理的下一代工具(综述)
Int J Oncol. 2025 May;66(5). doi: 10.3892/ijo.2025.5748. Epub 2025 May 9.
3
Catalase-Knockout Complements the Radio-Sensitization Effect of Titanium Peroxide Nanoparticles on Pancreatic Cancer Cells.

本文引用的文献

1
Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy.病毒载体和细胞外囊泡:CRISPR/Cas 介导的癌症治疗中使用的先天传递系统。
Cancer Gene Ther. 2023 Jul;30(7):936-954. doi: 10.1038/s41417-023-00597-z. Epub 2023 Feb 28.
2
Generation of CRISPR-Cas9-mediated genetic knockout human intestinal tissue-derived enteroid lines by lentivirus transduction and single-cell cloning.通过慢病毒转导和单细胞克隆技术生成 CRISPR-Cas9 介导的基因敲除人肠道组织衍生类器官系。
Nat Protoc. 2022 Apr;17(4):1004-1027. doi: 10.1038/s41596-021-00669-0. Epub 2022 Feb 23.
3
Using Synthetically Engineered Guide RNAs to Enhance CRISPR Genome Editing Systems in Mammalian Cells.
过氧化氢酶基因敲除可补充过氧化钛纳米颗粒对胰腺癌细胞的放射增敏作用。
Molecules. 2025 Jan 31;30(3):629. doi: 10.3390/molecules30030629.
利用合成工程化引导RNA增强哺乳动物细胞中的CRISPR基因组编辑系统。
Front Genome Ed. 2021 Jan 28;2:617910. doi: 10.3389/fgeed.2020.617910. eCollection 2020.
4
Optimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair.CRISPR Cas9 和 Cas12a 同源定向修复的优化设计参数。
Sci Rep. 2021 Sep 30;11(1):19482. doi: 10.1038/s41598-021-98965-y.
5
Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives.基于 CRISPR/Cas 的基因编辑系统的慢病毒载体:现状与展望。
Viruses. 2021 Jul 1;13(7):1288. doi: 10.3390/v13071288.
6
Simple, fast and efficient iTOP-mediated delivery of CRISPR/Cas9 RNP in difficult-to-transduce human cells including primary T cells.简单、快速、高效的 iTOP 介导的 CRISPR/Cas9 RNP 在包括原代 T 细胞在内的难转导人细胞中的递送。
J Biotechnol. 2021 Sep 10;338:71-80. doi: 10.1016/j.jbiotec.2021.07.006. Epub 2021 Jul 13.
7
A CRISPR view of the 2020 Nobel Prize in Chemistry.2020年诺贝尔化学奖的CRISPR视角。
J Clin Invest. 2021 Jan 4;131(1). doi: 10.1172/JCI145214.
8
Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?上皮细胞黏附分子 EpCAM 的表达和功能:40 年后我们在哪里?
Cancer Metastasis Rev. 2020 Sep;39(3):969-987. doi: 10.1007/s10555-020-09898-3.
9
Recent Advances in CRISPR/Cas9 Delivery Strategies.CRISPR/Cas9 递送策略的最新进展。
Biomolecules. 2020 May 30;10(6):839. doi: 10.3390/biom10060839.
10
CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing.CHOPCHOP v3:扩展 CRISPR 网络工具包,超越基因组编辑。
Nucleic Acids Res. 2019 Jul 2;47(W1):W171-W174. doi: 10.1093/nar/gkz365.